Gene Query: BUD13

Dataset Description Geneva Score
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 11.58
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 11.37
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 11.37
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 8.27
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 7.79
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 7.32
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 7.18
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.02
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.02
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 6.64
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 6.57
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 6.57
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 6.3
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 6.14
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 5.84
Seletive inhibition of CDK9 in DLBCL cell lines 5.82
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.68
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.68
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 5.66
Retinoic acid suppresses MYB in adenoid cystic carcinoma 5.62
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 5.62
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.54
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 5.44
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 5.37
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 5.33
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 5.16
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 4.75
ARID1A regulates condensin II distribution and chromosomal partition 4.35
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 4.35
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 4.28
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.28
FBXW7 modulates stress response by post-translational modification of HSF1 4.28
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 4.24
LncRNA-GAS5 negative regulation of YAP-target genes expression 4.17
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 4.13
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 4.13
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 4.13
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.09
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.09
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 3.98
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 3.92
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 3.92
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 3.83
Differential gene expression of human melanoma cells [RNA-seq] 3.83
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 3.8
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 3.8
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 3.79
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 3.74
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 3.73
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 3.68
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 3.62
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 3.61
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 3.6
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.57
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.57
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 3.57
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.55
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 3.45
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 3.42
Gene expression in PANC1 cells treated with Rakicidin 3.41
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 3.39
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 3.39
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 3.39
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 3.39
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.34
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 3.33
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 3.25
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 3.17
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 3.16
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 3.12
O-glcnAc reprograms cellular energetics 3.09
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.07
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 3.04
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 3.01
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.98
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 2.96
RNA expression analysis upon JMJD1C depletion 2.96
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 2.95
Effect of drugs on transcriptomic profiles 2.93
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.92
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 2.9
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.82
RNA-seq of cells with TET1 knockout 2.8
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 2.8
The evolution of N6-methyladenosine in primates 2.8
PRDM1 inhibits proliferation of human colon cancer organoids 2.78
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 2.75
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 2.75
Hijacking of stress response machinery by oncogenes in acute leukaemia 2.73
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 2.73
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 2.69
IMP3 regulated gene expression in breast cancer cells 2.67
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 2.64
TT-Seq captures the human transient transcriptome 2.63
Dynamic 3D chromosomal landscapes in acute leukemia 2.57
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.57
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 2.56
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 2.56
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 2.56
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.56
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 2.54
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 2.54
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 2.53
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 2.53
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 2.51
Accurate annotation of human protein-coding small open reading frames 2.47
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 2.47
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.47
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.44
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 2.44
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 2.44
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.36
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.36
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 2.36
Functional significance of the HIV-1 Tat signature amino acid residues 2.35
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  2.35
Transcriptomic analysis of ERR alpha orphan nuclear receptor 2.33
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 2.28
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 2.28
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 2.25
Transcriptome-wide identification of CELF2 functional targets in T cells 2.25
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.24
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 2.23
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 2.19
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 2.16
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 2.13
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 2.11
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 2.11
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.1
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.1
The conserved transcriptional landscapes in human spermatogenesis 2.07
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 2.03
Identification of global regulators of T-helper cell lineage specification 2.03
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 2.02
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.0
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.97
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 1.95
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 1.95
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 1.95
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 1.93
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 1.92
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 1.92
RNA-seq of YB5 cells treated with Proscillaridin A 1.91
Transcriptional profile in human S. haematobium infection 1.9
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 1.9
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 1.89
Targeting MTHFD2 in Acute Myeloid Leukemia 1.88
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 1.87
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 1.87
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 1.87
Global gene expression profile of dasatinib-resistant RCH-ACV cells 1.87
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 1.86
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 1.86
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 1.86
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 1.86
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 1.85
Inhibition of TNBC metastasis by Gpx1 1.85
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 1.84
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.84
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.83
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.83
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.83
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 1.82
Modulation of nonsense-mediated decay by rapamycin 1.8
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 1.79
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 1.79
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.79
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.79
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.76
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.76
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.75
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 1.75
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 1.74
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 1.74
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 1.74
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 1.73
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 1.73
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.72
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.72
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 1.72
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.72
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.72
RNA-seq of resting and activated CD4+ T cells +-JQ1 1.71
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 1.71
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 1.71
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 1.71
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 1.71
Transcription control by the ENL YEATS domain in acute leukemia 1.71
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.69
N6-methyladenine DNA Modification in Glioblastoma 1.69
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 1.69
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 1.69
RNA-seq analysis of differentiating human erythroblasts 1.67
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 1.67
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 1.66
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 1.66
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 1.66
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 1.65
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 1.65
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 1.62
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.62
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 1.62
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 1.62
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 1.62
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 1.61
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 1.59
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 1.59
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 1.58
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 1.58
Crizotinib v. DMSO in SW480 cells 1.58
Developmental stage specific chromosome architecture in human erythroid cells 1.58
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 1.58
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 1.58
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 1.58
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 1.57
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 1.57
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  1.57
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 1.56
Impact of dieldrin on transcription in Jurkat T cells 1.56
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 1.55
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 1.55
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 1.55
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 1.55
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 1.54
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 1.54
U1 snRNP telescripting regulates size-function stratified human genome 1.53
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 1.52
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.51
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 1.51
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 1.48
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 1.47
m6A-dependent regulation of messenger RNA stability 1.47
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 1.46
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 1.46
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 1.45
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.44
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 1.43
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 1.43
AUF-1 affected genes in human skin cells 1.42
RNA-Sequencing of HepG2 cells treated with TGFBeta 1.42
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 1.42
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.4
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.4
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 1.4
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 1.4
Cajal bodies are linked to genome conformation 1.4
Cajal bodies are linked to genome conformation [RNA-Seq] 1.4
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.4
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.39
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.39
RNAseq Study in CC-671 Treated Cal-51 Cells 1.39
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 1.38
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 1.38
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 1.37
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 1.36
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.35
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 1.35
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 1.35
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 1.35
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 1.34
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 1.33
Next Generation Sequencing of human SMA and healthy control Motor Neurons 1.32
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 1.32
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 1.32
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.32
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.31
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 1.3
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.3
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 1.3
A novel target of EZH1/2 for treatment of mantle cell lymphoma 1.29
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.28
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 1.28
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 1.28
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 1.27
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 1.27
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 1.26
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.26
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 1.25
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 1.25
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 1.25
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 1.25
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 1.24
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 1.23
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 1.21
SNHG5 siRNA knock down in HCT116 cells 1.2
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 1.19
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.18
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.18
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.18
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 1.18
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 1.17
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 1.17
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.17
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.16
TOP2B disturbed the quality of human oocytes with advanced maternal age 1.16
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.14
Tracking distinct RNA populations using efficient and reversible covalent chemistry 1.13
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.11
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.11
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.1
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.09
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 1.09
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.09
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.08
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 1.06
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 1.05
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.04
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 1.03
Effect of PRDM11 depletion in U2932 cells 1.02
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.0
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.99
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 0.99
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.98
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 0.97
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 0.97
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 0.96
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.96
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 0.96
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 0.95
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 0.95
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 0.95
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.94
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 0.93
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.93
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 0.92
Mapping interactions for the TNIP2 hub protein 0.92
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 0.91
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.9
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 0.89
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 0.89
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 0.88
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 0.88
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 0.88
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.88
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.88
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 0.87
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.87
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 0.86
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 0.86
Ribosome profiling upon inhibition of eIF4A 0.86
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.86
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.84
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 0.82
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 0.81
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 0.81
An integrative analysis of non-coding regulatory DNA variations associated with autism 0.8
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 0.8
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 0.79
RNA seq comparison between scrambled and shGRP78 cells 0.79
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.79
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.79
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.78
Oncogenic roles of ARID5B in T-ALL 0.78
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.78
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 0.77
Human cells contain natural double-stranded RNAs with potential regulatory capacity 0.77
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 0.76
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.75
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.74
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.73
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 0.73
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.72
Role of FGFR1 in neuronal devlopment 0.72
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 0.7
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.7
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.68
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 0.68
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.67
Transcriptomic analysis of LSD1 0.66
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 0.66
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.66
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 0.66
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.65
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.63
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.61
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.61
Loss of CREBBP results in gene expression repression in lymphoma cells 0.61
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.61
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.59
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 0.59
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 0.59
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 0.58
Function and hormonal regulation of GATA3 in human first trimester placentation 0.58
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 0.58
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.58
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 0.58
Transcriptome sequencing of K-562 cells 0.57
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.56
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.56
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.55
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.55
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.54
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.53
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.53
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 0.53
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.52
Downregulation of LATS kinases alters p53 to promote cell migration 0.52
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 0.52
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.51
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.5
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.49
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.49
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.49
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.49
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.49
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.48
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.47
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.47
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.47
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.47
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.46
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.46
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.45
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.45
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.45
KSDM1b Role in Ewing Sarcoma 0.44
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.44
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.44
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.44
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.43
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.43
CD73 knockdown effect in pancreatic cancer cell lines 0.42
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 0.4
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 0.4
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.4
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.4
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.38
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.37
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.36
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.34
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.33
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.33
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.33
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 0.32
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.32
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 0.32
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.32
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.31
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.31
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.31
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.3
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.3
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.29
Gene expression profile in breast cancer cells 0.29
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.28
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 0.28
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.28
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.27
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.27
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.26
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 0.26
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.25
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 0.25
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.24
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.24
siRNA-mediated knockdown 0.24
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.24
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.24
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.24
Expression analysis of the TAF1 syndrome 0.23
The cohesin complex prevents Myc-induced replication stress 0.22
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.18
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.18
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.18
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.17
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.16
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.16
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.15
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.15
Analyses of T-ALL (COG study) 0.15
RNA sequencing of T-ALL (COG study) 0.15
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.14
Gene expression analysis upon mtDNA depletion 0.13
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.13
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.13
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.13
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.11
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.11
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.1
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.1
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.09
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.09
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.08
Global transcriptome analysis of WT versus HEB-/- hESCs 0.08
6mer seed toxicity in tumour suppressive microRNAs 0.08
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.07
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.06
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.06
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.06
Transcriptome Profiling of Human Primary Monocytes 0.06
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.05
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.05
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.04
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.04
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.03
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.02
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.02
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.02
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.02
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation